Holmen S, Manintveld O, Damman K, Haugen Löfman I, Szymanski M, Braun O, Lando M, Bjørkelund E, Brugts JJ, Taverne YJHJ, Ter Maaten JM, Thorvaldsen T, Melin M, van der Meer MG, Fagerland MW, Ravnestad H, Gude E, Andreassen AK, Gullestad L, Broch K(2026) Dapagliflozin for Renal Protection in Heart Transplant Recipients: A Randomized Clinical Trial Circulation(in press) DOI 10.1161/CIRCULATIONAHA.126.083760, PubMed 42999953
Karim SR, Jensen NM, Holck EN, Clemmensen TS, Christiansen EH, Jakobsen L, Chen Z, Sonka M, Karason K, Broch K, Solberg OG, Eiskjær H(2026) Corrigendum to "Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipients" [J Heart Lung Transplant 45 (2026) 26-36] J Heart Lung Transplant(in press) DOI 10.1016/j.healun.2026.09.018, PubMed 42925292
Bjørkekjær HJ, Bruni C, Broch K, Brunborg C, Carreira PE, Airò P, Simeón-Aznar CP, Truchetet ME, Giollo A, Balbir-Gurman A, Martin M, Denton CP, Gabrielli A, Del Galdo F, Vonk MC, Fretheim H, Bitter H, Midtvedt Ø, Andreassen AK, Høie S, Tanaka Y, Riemekasten G, Müller-Ladner U, Matucci-Cerinic M, Castellví I, Siegert E, Hachulla E, Molberg Ø, Distler O, Hoffmann-Vold AMet al.(2026) Initial treatment strategies and outcomes across haemodynamic thresholds and risk stratification in incident systemic sclerosis-associated pulmonary arterial hypertension: a EUSTAR analysis Arthritis Rheumatol(in press) DOI 10.1002/art.70372, PubMed 42876376